Heartflow (HTFL) vs Envista (NVST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Heartflow (HTFL) has outperformed Envista (NVST) over the past year, gaining 41.1% versus a gain of 12.8%. Heartflow is the larger company by market cap ($4.29 billion vs $3.70 billion), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HTFL | NVST |
|---|---|---|
| Share price | $49.36 | $23.04 |
| Market cap | $4.29B | $3.70B |
| 1-day change | -2.62% | -0.99% |
| YTD return | +69.33% | +6.13% |
| 1-year return | +41.07% | +12.83% |
| 5-year return | — | -40.50% |
| P/E ratio (TTM) | — | 39.72 |
| Forward P/E | — | 13.85 |
| EPS (TTM) | $-0.24 | $0.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $176.03M | — |
| Revenue growth (YoY) | +39.92% | — |
| Net income (latest FY) | $-116.79M | — |
| Gross margin | 76.80% | — |
| Operating margin | -36.39% | — |
| Net margin | -66.35% | — |
| 52-week high | $54.32 | $30.42 |
| 52-week low | $20.13 | $18.77 |
| Distance from 52-week high | -9.13% | -24.26% |
| Analyst consensus | none | buy |
| Avg. price target upside | -6.81% | +28.86% |
| Average volume | 1.79M | 2.84M |
| Shares outstanding | 86.95M | 160.62M |
| Employees | 843 | 12,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HTFL has outperformed NVST by 28.2 percentage points over the past year.
About Heartflow
HTFL stock →HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
Health Care · Medical/Dental Instruments · 843 employees
About Envista
NVST stock →Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.
Health Care · Medical/Dental Instruments · 12,000 employees
HTFL vs NVST FAQ
Which is bigger, Heartflow or Envista?
Heartflow (HTFL) is larger, with a market capitalization of $4.29B compared with $3.70B for Envista (NVST).
Which stock has performed better over the past year, HTFL or NVST?
HTFL returned +41.07% over the past 12 months, compared with +12.83% for NVST (price return, excluding dividends). Past performance does not predict future results.
Are Heartflow and Envista in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.